Corrigendum: Triplebody Mediates Increased Anti-Leukemic Reactivity of IL-2 Activated Donor Natural Killer (NK) Cells and Impairs Viability of Their CD33-Expressing NK Subset.

Authors :: Kloess S
Ede Valverde da Silva A
Oberschmidt O
Gardlowski T
Matthies N
Vyas M
Arseniev L
Heuser M
Pogge von Strandmann E
Köhl U
Source :: Frontiers in immunology [Front Immunol] 2018 Oct 08; Vol. 9, pp. 2326. Date of Electronic Publication: 2018 Oct 08 (Print Publication: 2018).
Publication Year :: 2018
Abstract: [This corrects the article DOI: 10.3389/fimmu.2017.01100.].

Full Text Access

Tools